Thrivent Financial for Lutherans’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $562K | Sell |
|
|||||
|
2025
Q1 | $544K | Sell |
|
|||||
|
2024
Q4 | $1.73M | Sell |
|
|||||
|
2024
Q3 | $2.18M | Buy |
|
|||||
|
2024
Q2 | $1.99M | Sell |
|
|||||
|
2024
Q1 | $2.26M | Buy |
|
|||||
|
2023
Q4 | $1.81M | Buy |
|
|||||
|
2023
Q3 | $1.16M | Sell |
|
|||||
|
2023
Q2 | $1.15M | Buy |
|
|||||
|
2023
Q1 | $1.13M | Buy |
|
|||||
|
2022
Q4 | $1.11M | Buy |
|
|||||
|
2022
Q3 | $901K | Sell |
|
|||||
|
2022
Q2 | $71.2M | Buy |
|
|||||
|
2022
Q1 | $42.5M | Buy |
|
|||||
|
2021
Q4 | $40.9M | Buy |
|
|||||
|
2021
Q3 | $34.7M | Buy |
|
|||||
|
2021
Q2 | $36M | Buy |
|
|||||
|
2021
Q1 | $32M | Buy |
|
|||||
|
2020
Q4 | $32.2M | Sell |
|
|||||
|
2020
Q3 | $34.2M | Sell |
|
|||||
|
2020
Q2 | $37.7M | Buy |
|
|||||
|
2020
Q1 | $344K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $2.35M | Sell |
|
|||||
|
2019
Q2 | $2.33M | Buy |
|
|||||
|
2019
Q1 | $1.65M | Sell |
|
|||||
|
2018
Q4 | $2.08M | Sell |
|
|||||
|
2018
Q3 | $53M | Buy |
|
|||||
|
2018
Q2 | $52.8M | Sell |
|
|||||
|
2018
Q1 | $53.4M | Sell |
|
|||||
|
2017
Q4 | $51.8M | Sell |
|
|||||
|
2017
Q3 | $61.2M | Buy |
|
|||||
|
2017
Q2 | $64.4M | Buy |
|
|||||
|
2017
Q1 | $57.9M | Buy |
|
|||||
|
2016
Q4 | $62K | Sell |
|
|||||
|
2016
Q3 | $111K | Sell |
|
|||||
|
2016
Q2 | $115K | Buy |
|
|||||
|
2016
Q1 | $106K | Hold |
|
|||||
|
2015
Q4 | $103K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $106K | Hold |
|
|||||
|
2015
Q1 | $121K | Sell |
|
|||||
|
2014
Q4 | $113K | Buy |
|
|||||
|
2014
Q3 | $73K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $265 | Buy |
|